title: Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy-Adjuvant versus Early Salvage (RAVES) trial.
authors.forename: Samir S
authors.initials: SS
authors.lastname: Taneja
mesh_terms: D000230:Adenocarcinoma / Q000532:radiotherapy*; D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D018714:Radiotherapy, Adjuvant; D016879:Salvage Therapy
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal